expert corner
There is an urgent need of fast track approvals and standardization of drug quality in the country.
With the increased noise level in the social and channel media as well as information explosion through the internet, there has been a gradual increase in the understanding about the disease among the general population at large.
otherwise not available medicines in India. Researchers in the country have a lot to offer in this regard through incremental innovation. Finding safer and better delivery mechanisms for the existing therapy options will be a significant contribution
New targets being focused- As there are newer and newer pathways of cancer formation being identified day by day, focus is now more on targeting them through specific molecules designed for specific pathways or receptors. Different ethnic patient groups are being focused to make treatments more effective. Government and industry partnership through funding research on these parameters in India is much needed given the patient load our country has.
Genetic level test – Genetic tests are available nowadays to detect some of the cancer types which are hereditary in nature. It also helps people to take the necessary steps to save future generation from falling prey to the deadly disease. Companion diagnostics suggesting personalized medicines for patients are also on the offer now from global organizations. Cost of these tests are still on the higher side for Indian patients considering the cost of treatment.
Diagnostic methods- There are novel diagnostic tools being available now which go a long way to help in easing treatment options. The advancement in diagnostic methods helps in diagnosis of the specific mutation and the risk the patient is suffering.
This is a significant
26 BioVoiceNews | September 2017